RxDoctor Payments Data

Salvatore Zavarella, DO

Neurological Surgery · West Islip, NYNPI 1174953129

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $124,937 of the $161,425 with a category attached, or 77.4%. Royal Biologics, Inc. accounts for 79.4% of it on its own, with 18 other manufacturers making up the rest. Among neurological surgery clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$161,425in general payments, 2019–2025

Across 207 payments — averaging $779.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Royal Biologics, Inc.$128K
  • Globus Medical$17K
  • Alphatec Spine, Inc$13K
  • Zimvie Inc.$852
  • Zimmer Biomet$562
  • Orthofix Medical, Inc.$295
  • plus $2K from 13 others

What the payments were for

  • Royalty or licence$124,93777%
  • Consulting fees$20,37513%
  • Travel & lodging$8,7545%
  • Food & beverage$7,3605%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$161,425 in reported general payments places this provider in the 90th percentile of 446 neurological surgery providers in New York.

See all neurological surgery providers in New York

Medicare billing

Part B allowed, 2024
$205,362
Medicare patients
192
Services billed
795

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin20$346
Methocarbamol26$182
Methylprednisolone18$130
Oxycodone Hcl11$67

Paid to pharmacies, not to this prescriber.

Other neurological surgery in West Islip

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →